Tirzepatide
Dual GIP/GLP-1 receptor agonist compounded for individual patients. Licensed 503A pharmacy with third-party potency testing and wholesale pricing.
About
Tirzepatide is a dual GIP/GLP-1 receptor agonist used in medical weight management. Originally marketed as Mounjaro® and Zepbound® by Eli Lilly, compounded tirzepatide is available from licensed 503A pharmacies for individual patients when commercially manufactured versions are unavailable or in shortage.
Promise Pharmacy compounds tirzepatide in multiple concentrations to support standard dose titration protocols. Each vial is prepared for an individual patient based on a valid prescription from a licensed provider.
Process
Apply through our partner program with your medical license and DEA registration.
Choose the tirzepatide concentration matching your titration protocol.
Submit individual patient prescriptions through the provider portal.
We compound and ship within 5 business days with proper cold chain packaging.
FAQ